Terug
Dagbereik
€ 19,41
€ 20,46
52-Weeksbereik
€ 1,60
€ 25,17
Volume
140.803
50D / 200D Gem.
€ 18,43
/
€ 10,24
Vorige Slotkoers
€ 20,02
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,9 | 0,3 |
| P/B | 4,2 | 3,0 |
| ROE % | -41,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 26,33
+30.4%
Low: € 16,00
High: € 35,00
Forward WPA
-€ 2,41
Omzet Sch.
0,0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,09
€ 1,09 – € 1,09
|
294,45M | 2 |
| FY2029 |
-€ 2,41
-€ 2,41 – -€ 2,41
|
49,02M | 4 |
| FY2028 |
-€ 2,88
-€ 4,11 – -€ 2,15
|
9,30M | 6 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -51,79M
PEG of 0,65 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-41,80%
ROIC-32,00%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,03
Current Ratio15,69
Interest Coverage-26,88
Waardering
P/E Ratio
-9,92
Forward P/EN/A
P/B Ratio4,15
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -63,24M |
| ROE | -41,80% | ROA | -34,24% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -51,79M |
| ROIC | -32,00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 15,69 |
| Interest Coverage | -26,88 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9,92 | Forward P/E | N/A |
| P/B Ratio | 4,15 | P/S Ratio | N/A |
| PEG Ratio | 0,65 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,26% | ||
| Market Cap | 627,23M | Enterprise Value | 455,15M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 210.000,0 |
| Net Income | -63,24M | -61,43M | -36,31M | -27,71M | -9,19M |
| EPS (Diluted) | -2,19 | -2,50 | -1,35 | -1,08 | -0,36 |
| Gross Profit | -661.000,0 | -502.000,0 | 0,0 | -342.000,0 | 65.000,0 |
| Operating Income | -66,36M | -68,61M | -37,81M | -29,19M | -12,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 184,69M | 177,54M | 86,63M | 50,85M | 28,79M |
| Total Liabilities | 33,55M | 26,08M | 158,30M | 89,26M | 41,27M |
| Shareholders' Equity | 151,14M | 151,46M | -71,67M | -38,41M | -12,48M |
| Total Debt | 4,41M | 16,94M | 9,99M | 82,11M | 38,16M |
| Cash & Equivalents | 176,48M | 168,23M | 82,55M | 48,34M | 25,71M |
| Current Assets | 177,72M | 169,34M | 85,39M | 49,22M | 27,68M |
| Current Liabilities | 11,33M | 10,01M | 5,61M | 5,56M | 1,81M |